;PMID: 99592
;source_file_898.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..39] = [t:0..39]
;1)sentence:[e:45..134] = [t:45..134]
;2)section:[e:138..157] = [t:138..156]
;3)sentence:[e:161..380] = [t:161..380]
;4)sentence:[e:381..487] = [t:381..487]
;5)sentence:[e:488..617] = [t:488..617]
;6)sentence:[e:618..786] = [t:618..786]
;7)sentence:[e:787..886] = [t:787..886]
;8)sentence:[e:887..1065] = [t:887..1065]
;9)sentence:[e:1066..1321] = [t:1066..1321]
;10)sentence:[e:1322..1426] = [t:1322..1426]
;11)sentence:[e:1427..1633] = [t:1427..1633]
;12)sentence:[e:1634..1678] = [t:1634..1678]
;13)section:[e:1682..1724] = [t:1682..1723]
;Sentence Matching Errors
;ERROR_Section end mismatch[e:138..157][t:138..156]
;ERROR_Section end mismatch[e:1682..1724][t:1682..1723]
;Token/POS Errors
;ERROR_Token in entity file but not tree[30..31] )
;ERROR_Token in entity file but not tree[31..32] :
;ERROR_Token in entity file but not tree[156..157] .
;ERROR_Token in entity file but not tree[1723..1724] ]
;ERROR_POS mismatch [22..25] t:token e:NNP Apr
;ERROR_Token in tree file but not entity[30..32] ):

;section 0 Span:0..39
;Jpn J Pharmacol. 1978 Apr;28(2):305-15.
(SEC
  (FRAG (NNP:[0..3] Jpn) (NNP:[4..5] J) (NNP:[6..15] Pharmacol) (.:[15..16] .)
        (CD:[17..21] 1978) (token:[22..25] Apr) (::[25..26] ;) (CD:[26..28] 28)
        (-LRB-:[28..29] -LRB-) (CD:[29..30] 2) (-RRB-:[30..32] -RRB-:)
        (CD:[32..35] 305) (::[35..36] -) (CD:[36..38] 15) (.:[38..39] .)))

;sentence 1 Span:45..134
;Polychlorinated dibenzofurans--potent inducers of rat hepatic
;drug-metabolizing  enzymes.
;[45..74]:substance:"Polychlorinated dibenzofurans"
;[83..91]:substance:"inducers"
;[107..111]:substance:"drug"
;[126..133]:substance:"enzymes"
(SENT
  (NP-HLN
    (NP (JJ:[45..60] Polychlorinated) (NNS:[61..74] dibenzofurans))
    (::[74..76] --)
    (NP
      (NP (JJ:[76..82] potent) (NNS:[83..91] inducers))
      (PP (IN:[92..94] of)
        (NP (NN:[95..98] rat) (JJ:[99..106] hepatic)
          (ADJP (NN:[107..111] drug) (HYPH:[111..112] -)
                (VBG:[112..124] metabolizing))
          (NNS:[126..133] enzymes))))
    (.:[133..134] .)))

;section 2 Span:138..156
;Kawano S, Hiraga K
(SEC
  (FRAG (NNP:[138..144] Kawano) (NNP:[145..146] S) (,:[146..147] ,)
        (NNP:[148..154] Hiraga) (NNP:[155..156] K)))

(ORPH .)

;sentence 3 Span:161..380
;The effects of polychlorinated dibenzofurans (PCDFs), trace toxic
;contaminants  of commercial polychlorinated biphenyl preparations (PCBs), on
;the induction of  hepatic drug-metabolizing enzymes were studied in the rat.
;[176..205]:substance:"polychlorinated dibenzofurans"
;[207..212]:substance:"PCDFs"
;[227..239]:substance:"contaminants"
;[255..292]:substance:"polychlorinated biphenyl preparations"
;[294..298]:substance:"PCBs"
;[330..334]:substance:"drug"
;[348..355]:substance:"enzymes"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[161..164] The) (NNS:[165..172] effects))
      (PP (IN:[173..175] of)
        (NP
          (NP
            (NP (JJ:[176..191] polychlorinated) (NNS:[192..205] dibenzofurans))
            (NP (-LRB-:[206..207] -LRB-) (NNS:[207..212] PCDFs)
                (-RRB-:[212..213] -RRB-)))
          (,:[213..214] ,)
          (NP
            (NP (JJ:[215..220] trace) (JJ:[221..226] toxic)
                (NNS:[227..239] contaminants))
            (PP (IN:[241..243] of)
              (NP (JJ:[244..254] commercial)
                (NML
                  (NML (JJ:[255..270] polychlorinated) (NN:[271..279] biphenyl)
                       (NNS:[280..292] preparations))
                  (NML (-LRB-:[293..294] -LRB-) (NNS:[294..298] PCBs)
                       (-RRB-:[298..299] -RRB-))))))))
      (,:[299..300] ,)
      (PP (IN:[301..303] on)
        (NP
          (NP (DT:[304..307] the) (NN:[308..317] induction))
          (PP (IN:[318..320] of)
            (NP (JJ:[322..329] hepatic)
              (ADJP (NN:[330..334] drug) (HYPH:[334..335] -)
                    (VBG:[335..347] metabolizing))
              (NNS:[348..355] enzymes))))))
    (VP (VBD:[356..360] were)
      (VP (VBN:[361..368] studied)
        (NP-1 (-NONE-:[368..368] *))
        (PP (IN:[369..371] in)
          (NP (DT:[372..375] the) (NN:[376..379] rat)))))
    (.:[379..380] .)))
;ERROR_Orphan Text from Tree File[156..161] .

;sentence 4 Span:381..487
;PCDFs were about a  thousand times more potent than PCBs (Kanechlor-500) as
;inducers of cytochrome  P-450.
;[381..386]:substance:"PCDFs"
;[401..415]:quantitative-value:"thousand times"
;[433..437]:substance:"PCBs"
;[439..452]:substance:"Kanechlor-500"
;[457..465]:substance:"inducers"
;[469..486]:cyp450:"cytochrome  P-450"
(SENT
  (S
    (NP-SBJ (NNS:[381..386] PCDFs))
    (VP (VBD:[387..391] were)
      (NP-PRD
        (NP
          (QP (RB:[392..397] about) (DT:[398..399] a)
             (CD:[401..409] thousand) (NNS:[410..415] times))
          (RBR:[416..420] more) (JJ:[421..427] potent))
        (PP (IN:[428..432] than)
          (NP (NNS:[433..437] PCBs)))
        (PRN (-LRB-:[438..439] -LRB-)
          (NP (NNP:[439..448] Kanechlor) (HYPH:[448..449] -) (CD:[449..452] 500))
          (-RRB-:[452..453] -RRB-)))
      (PP (IN:[454..456] as)
        (NP
          (NP (NNS:[457..465] inducers))
          (PP (IN:[466..468] of)
            (NP (NN:[469..479] cytochrome) (NN:[481..486] P-450))))))
    (.:[486..487] .)))

;sentence 5 Span:488..617
;Rats given 10 microgram/kg of PCDFs intraperitoneally for 3 days showed 
;significantly increased hepatic cytochrome P-450 levels.
;[499..501]:quantitative-value:"10"
;[502..514]:quantitative-units:"microgram/kg"
;[518..523]:substance:"PCDFs"
;[546..547]:quantitative-value:"3"
;[548..552]:quantitative-units:"days"
;[593..609]:cyp450:"cytochrome P-450"
(SENT
  (S
    (NP-SBJ
      (NP (NNS:[488..492] Rats))
      (VP (VBN:[493..498] given)
        (NP (-NONE-:[498..498] *))
        (NP
          (NP (CD:[499..501] 10) (NN:[502..511] microgram))
          (PP (SYM:[511..512] /)
            (NP (NN:[512..514] kg)))
          (PP (IN:[515..517] of)
            (NP (NNS:[518..523] PCDFs))))
        (ADVP-MNR (RB:[524..541] intraperitoneally))
        (PP-TMP (IN:[542..545] for)
          (NP (CD:[546..547] 3) (NNS:[548..552] days)))))
    (VP (VBD:[553..559] showed)
      (NP
        (ADJP (RB:[561..574] significantly) (VBD:[575..584] increased))
        (JJ:[585..592] hepatic)
        (NML (NN:[593..603] cytochrome) (NN:[604..609] P-450))
        (NNS:[610..616] levels)))
    (.:[616..617] .)))

;sentence 6 Span:618..786
;At the highest dose  tested, 1000 microgram/kg, a two-fold increase of
;cytochrome P-450 and a  three-fold increase of p-nitroanisole demethylase
;activity were observed.
;[647..651]:quantitative-value:"1000"
;[652..664]:quantitative-units:"microgram/kg"
;[668..676]:quantitative-value:"two-fold"
;[689..705]:cyp450:"cytochrome P-450"
;[713..723]:quantitative-value:"three-fold"
;[736..762]:substance:"p-nitroanisole demethylase"
(SENT
  (S
    (PP (IN:[618..620] At)
      (NP
        (NP
          (NP (DT:[621..624] the) (JJS:[625..632] highest) (NN:[633..637] dose))
          (VP (VBN:[639..645] tested)
            (NP (-NONE-:[645..645] *))))
        (,:[645..646] ,)
        (NP
          (NP (CD:[647..651] 1000) (NN:[652..661] microgram))
          (PP (SYM:[661..662] /)
            (NP (NN:[662..664] kg))))))
    (,:[664..665] ,)
    (NP-SBJ-1
      (NP
        (NP (DT:[666..667] a)
          (QP (CD:[668..671] two) (HYPH:[671..672] -) (JJ:[672..676] fold))
          (NN:[677..685] increase))
        (PP (IN:[686..688] of)
          (NP (NN:[689..699] cytochrome) (NN:[700..705] P-450))))
      (CC:[706..709] and)
      (NP
        (NP (DT:[710..711] a)
          (QP (CD:[713..718] three) (HYPH:[718..719] -) (JJ:[719..723] fold))
          (NN:[724..732] increase))
        (PP (IN:[733..735] of)
          (NP
             (NN:[736..750] p-nitroanisole) (NN:[751..762] demethylase)
            (NN:[763..771] activity)))))
    (VP (VBD:[772..776] were)
      (VP (VBN:[777..785] observed)
        (NP-1 (-NONE-:[785..785] *))))
    (.:[785..786] .)))

;sentence 7 Span:787..886
;PCDFs  and 3-methylcholanthrene had quite similar effects on microsomal 
;drug-metabolizing enzymes.
;[787..792]:substance:"PCDFs"
;[798..818]:substance:"3-methylcholanthrene"
;[860..864]:substance:"drug"
;[878..885]:substance:"enzymes"
(SENT
  (S
    (NP-SBJ (NNS:[787..792] PCDFs) (CC:[794..797] and)
            (NN:[798..818] 3-methylcholanthrene))
    (VP (VBD:[819..822] had)
      (NP
        (NP
          (ADJP (RB:[823..828] quite) (JJ:[829..836] similar))
          (NNS:[837..844] effects))
        (PP (IN:[845..847] on)
          (NP (JJ:[848..858] microsomal)
            (ADJP (NN:[860..864] drug) (HYPH:[864..865] -)
                  (VBG:[865..877] metabolizing))
            (NNS:[878..885] enzymes)))))
    (.:[885..886] .)))

;sentence 8 Span:887..1065
;Both drugs increased p-nitroanisole demethylase  activity strikingly and
;aniline hydroxylase activity moderately, but produced  little change in
;aminopyrine demethylase activity.
;[892..897]:substance:"drugs"
;[908..934]:substance:"p-nitroanisole demethylase"
;[960..979]:cyp450:"aniline hydroxylase"
;[1032..1055]:substance:"aminopyrine demethylase"
(SENT
  (S
    (NP-SBJ (DT:[887..891] Both) (NNS:[892..897] drugs))
    (VP
      (VP
        (VP (VBD:[898..907] increased)
          (NP=1
             (NN:[908..922] p-nitroanisole) (NN:[923..934] demethylase)
            (NN:[936..944] activity))
          (ADVP=2 (RB:[945..955] strikingly)))
        (CC:[956..959] and)
        (VP
          (NP=1
             (NN:[960..967] aniline) (NN:[968..979] hydroxylase)
            (NN:[980..988] activity))
          (ADVP=2 (RB:[989..999] moderately))))
      (,:[999..1000] ,) (CC:[1001..1004] but)
      (VP (VBD:[1005..1013] produced)
        (NP
          (NP (JJ:[1015..1021] little) (NN:[1022..1028] change))
          (PP (IN:[1029..1031] in)
            (NP
               (NN:[1032..1043] aminopyrine) (NN:[1044..1055] demethylase)
              (NN:[1056..1064] activity))))))
    (.:[1064..1065] .)))

;sentence 9 Span:1066..1321
;alpha-Naphthoflavone, which  is known to be a specific inhibitor of aryl
;hydrocarbon hydroxylase induced by  polycyclic aromatic hydrocarbons,
;inhibited at low concentrations p-nitroanisole  demethylase activity of rats
;previously treated with both drugs.
;[1066..1086]:substance:"alpha-Naphthoflavone"
;[1121..1130]:substance:"inhibitor"
;[1134..1162]:cyp450:"aryl hydrocarbon hydroxylase"
;[1175..1207]:substance:"polycyclic aromatic hydrocarbons"
;[1241..1268]:substance:"p-nitroanisole  demethylase"
;[1315..1320]:substance:"drugs"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1066..1086] alpha-Naphthoflavone))
      (,:[1086..1087] ,)
      (SBAR
        (WHNP-1 (WDT:[1088..1093] which))
        (S
          (NP-SBJ-1 (-NONE-:[1093..1093] *T*))
          (VP (VBZ:[1095..1097] is)
            (VP (VBN:[1098..1103] known)
              (S
                (NP-SBJ-1 (-NONE-:[1103..1103] *))
                (VP (TO:[1104..1106] to)
                  (VP (VB:[1107..1109] be)
                    (NP-PRD
                      (NP
                        (NP (DT:[1110..1111] a) (JJ:[1112..1120] specific)
                            (NN:[1121..1130] inhibitor))
                        (PP (IN:[1131..1133] of)
                          (NP (NN:[1134..1138] aryl)
                              (NN:[1139..1150] hydrocarbon)
                              (NN:[1151..1162] hydroxylase))))
                      (VP (VBN:[1163..1170] induced)
                        (NP (-NONE-:[1170..1170] *))
                        (PP (IN:[1171..1173] by)
                          (NP (JJ:[1175..1185] polycyclic)
                              (JJ:[1186..1194] aromatic)
                              (NNS:[1195..1207] hydrocarbons)))))))))))))
    (,:[1207..1208] ,)
    (VP (VBD:[1209..1218] inhibited)
      (PP (IN:[1219..1221] at)
        (NP (JJ:[1222..1225] low) (NNS:[1226..1240] concentrations)))
      (NP
        (NP
           (NN:[1241..1255] p-nitroanisole) (NN:[1257..1268] demethylase)
          (NN:[1269..1277] activity))
        (PP (IN:[1278..1280] of)
          (NP
            (NP (NNS:[1281..1285] rats))
            (VP
              (ADVP (RB:[1286..1296] previously))
              (VBN:[1297..1304] treated)
              (NP (-NONE-:[1304..1304] *))
              (PP-MNR (IN:[1305..1309] with)
                (NP (DT:[1310..1314] both) (NNS:[1315..1320] drugs))))))))
    (.:[1320..1321] .)))

;sentence 10 Span:1322..1426
;Further, both  drugs increased the 455 nm to 430 nm peak ratios of ethyl
;isocyanide difference  spectra.
;[1337..1342]:substance:"drugs"
;[1357..1360]:quantitative-value:"455"
;[1361..1363]:quantitative-units:"nm"
;[1367..1370]:quantitative-value:"430"
;[1371..1373]:quantitative-units:"nm"
;[1389..1405]:substance:"ethyl isocyanide"
(SENT
  (S
    (ADVP (RB:[1322..1329] Further))
    (,:[1329..1330] ,)
    (NP-SBJ (DT:[1331..1335] both) (NNS:[1337..1342] drugs))
    (VP (VBD:[1343..1352] increased)
      (NP (DT:[1353..1356] the)
        (NML
          (NML (CD:[1357..1360] 455) (NN:[1361..1363] nm))
          (PP (TO:[1364..1366] to)
            (NP (CD:[1367..1370] 430) (NN:[1371..1373] nm))))
        (NN:[1374..1378] peak) (NNS:[1379..1385] ratios))
      (PP (IN:[1386..1388] of)
        (NP
          (NML (NN:[1389..1394] ethyl) (NN:[1395..1405] isocyanide))
          (NN:[1406..1416] difference) (NNS:[1418..1425] spectra))))
    (.:[1425..1426] .)))

;sentence 11 Span:1427..1633
;Following three daily doses of PCDFs (100 microgram/kg), cytochrome  P-450
;level and p-nitroanisole demethylase activity remained elevated for over  15
;days, with a decrease to control levels after 30 days.
;[1437..1442]:quantitative-value:"three"
;[1443..1448]:quantitative-units:"daily"
;[1458..1463]:substance:"PCDFs"
;[1465..1468]:quantitative-value:"100"
;[1469..1481]:quantitative-units:"microgram/kg"
;[1484..1501]:cyp450:"cytochrome  P-450"
;[1512..1538]:substance:"p-nitroanisole demethylase"
;[1576..1578]:quantitative-value:"15"
;[1579..1583]:quantitative-units:"days"
;[1625..1627]:quantitative-value:"30"
;[1628..1632]:quantitative-units:"days"
(SENT
  (S
    (S-ADV
      (NP-SBJ (-NONE-:[1427..1427] *))
      (VP (VBG:[1427..1436] Following)
        (NP
          (NP (CD:[1437..1442] three) (JJ:[1443..1448] daily)
              (NNS:[1449..1454] doses))
          (PP (IN:[1455..1457] of)
            (NP (NNS:[1458..1463] PCDFs)))
          (PRN (-LRB-:[1464..1465] -LRB-)
            (NP
              (NP (CD:[1465..1468] 100) (NN:[1469..1478] microgram))
              (PP (SYM:[1478..1479] /)
                (NP (NN:[1479..1481] kg))))
            (-RRB-:[1481..1482] -RRB-)))))
    (,:[1482..1483] ,)
    (NP-SBJ
      (NP
        (NML (NN:[1484..1494] cytochrome) (NN:[1496..1501] P-450))
        (NN:[1502..1507] level))
      (CC:[1508..1511] and)
      (NP
        (NML (NN:[1512..1526] p-nitroanisole) (NN:[1527..1538] demethylase))
        (NN:[1539..1547] activity)))
    (VP (VBD:[1548..1556] remained)
      (ADJP-PRD (JJ:[1557..1565] elevated))
      (PP-TMP (IN:[1566..1569] for)
        (PP (IN:[1570..1574] over)
          (NP (CD:[1576..1578] 15) (NNS:[1579..1583] days))))
      (,:[1583..1584] ,)
      (PP (IN:[1585..1589] with)
        (NP
          (NP (DT:[1590..1591] a) (NN:[1592..1600] decrease))
          (PP (TO:[1601..1603] to)
            (NP (NN:[1604..1611] control) (NNS:[1612..1618] levels)))
          (PP-TMP (IN:[1619..1624] after)
            (NP (CD:[1625..1627] 30) (NNS:[1628..1632] days))))))
    (.:[1632..1633] .)))

;sentence 12 Span:1634..1678
;Such indicates the  slow excretion of PCDFs.
;[1672..1677]:substance:"PCDFs"
(SENT
  (S
    (NP-SBJ (JJ:[1634..1638] Such))
    (VP (VBZ:[1639..1648] indicates)
      (NP
        (NP (DT:[1649..1652] the) (JJ:[1654..1658] slow)
            (NN:[1659..1668] excretion))
        (PP (IN:[1669..1671] of)
          (NP (NNS:[1672..1677] PCDFs)))))
    (.:[1677..1678] .)))

;section 13 Span:1682..1723
;PMID: 99592 [PubMed - indexed for MEDLINE
(SEC
  (FRAG (NNP:[1682..1686] PMID) (::[1686..1687] :) (CD:[1688..1693] 99592)
        (-LRB-:[1694..1695] -LSB-) (NNP:[1695..1701] PubMed) (::[1702..1703] -)
        (VBN:[1704..1711] indexed) (IN:[1712..1715] for)
        (NNP:[1716..1723] MEDLINE)))
;ERROR_Orphan Text from EOF Tree File[1723..EOF] ]

(ORPH -RSB-)
